These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 1730513

  • 1. A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.
    Ye JN, Cheung NK.
    Int J Cancer; 1992 Jan 21; 50(2):197-201. PubMed ID: 1730513
    [Abstract] [Full Text] [Related]

  • 2. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
    Cheung NK, Canete A, Cheung IY, Ye JN, Liu C.
    Int J Cancer; 1993 May 28; 54(3):499-505. PubMed ID: 8509225
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.
    Saito M, Yu RK, Cheung NK.
    Biochem Biophys Res Commun; 1985 Feb 28; 127(1):1-7. PubMed ID: 2579648
    [Abstract] [Full Text] [Related]

  • 4. Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells.
    Sjoberg ER, Manzi AE, Khoo KH, Dell A, Varki A.
    J Biol Chem; 1992 Aug 15; 267(23):16200-11. PubMed ID: 1644805
    [Abstract] [Full Text] [Related]

  • 5. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB, Helling F, Lloyd KO, Livingston PO.
    Int J Cancer; 1993 Feb 20; 53(4):566-73. PubMed ID: 8436430
    [Abstract] [Full Text] [Related]

  • 6. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
    Nishio M, Furukawa K.
    Nagoya J Med Sci; 2004 May 20; 67(1-2):35-44. PubMed ID: 15279066
    [Abstract] [Full Text] [Related]

  • 7. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
    Kawashima I, Kotani M, Ozawa H, Suzuki M, Tai T.
    Int J Cancer; 1994 Jul 15; 58(2):263-8. PubMed ID: 8026889
    [Abstract] [Full Text] [Related]

  • 8. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells.
    Gross N, Beck D, Portoukalian J, Favre S, Carrel S.
    Int J Cancer; 1989 Apr 15; 43(4):665-71. PubMed ID: 2467885
    [Abstract] [Full Text] [Related]

  • 9. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
    Tai T, Kawashima I, Tada N, Dairiki K.
    J Biochem; 1988 Apr 15; 103(4):682-7. PubMed ID: 3170507
    [Abstract] [Full Text] [Related]

  • 10. Different reactivities of monoclonal antibodies to ganglioside lactones.
    Tai T, Kawashima I, Tada N, Ikegami S.
    Biochim Biophys Acta; 1988 Jan 19; 958(1):134-8. PubMed ID: 3334863
    [Abstract] [Full Text] [Related]

  • 11. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA, Ravindranath MH, Soh D, Gonzales A, Ye W, Morton DL.
    Cancer J; 2002 Jan 19; 8(5):384-94. PubMed ID: 12416896
    [Abstract] [Full Text] [Related]

  • 12. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
    Cheung NK, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM.
    Cancer Res; 1994 Apr 15; 54(8):2228-33. PubMed ID: 8174131
    [Abstract] [Full Text] [Related]

  • 13. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
    Lunn MP, Johnson LA, Fromholt SE, Itonori S, Huang J, Vyas AA, Hildreth JE, Griffin JW, Schnaar RL, Sheikh KA.
    J Neurochem; 2000 Jul 15; 75(1):404-12. PubMed ID: 10854286
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
    Kawashima I, Tada N, Fujimori T, Tai T.
    J Biochem; 1990 Jul 15; 108(1):109-15. PubMed ID: 2121721
    [Abstract] [Full Text] [Related]

  • 15. Binding of monoclonal antibody A2B5 to gangliosides.
    Kundu SK, Pleatman MA, Redwine WA, Boyd AE, Marcus DM.
    Biochem Biophys Res Commun; 1983 Nov 15; 116(3):836-42. PubMed ID: 6651849
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL, Fromholt SE, Gong Y, Vyas AA, Laroy W, Wayman DM, Heffer-Lauc M, Ito H, Ishida H, Kiso M, Griffin JW, Shiekh KA.
    Anal Biochem; 2002 Mar 15; 302(2):276-84. PubMed ID: 11878808
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats.
    Bergman I, Pohl CR, Venkataramanan R, Burckart GJ, Stabin M, Barmada MA, Griffin JA, Cheung NK.
    J Immunother; 1999 Mar 15; 22(2):114-23. PubMed ID: 10093036
    [Abstract] [Full Text] [Related]

  • 18. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K.
    J Cell Biol; 1986 Mar 15; 102(3):688-96. PubMed ID: 3005335
    [Abstract] [Full Text] [Related]

  • 19. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
    Cheung NK, Neely JE, Landmeier B, Nelson D, Miraldi F.
    J Nucl Med; 1987 Oct 15; 28(10):1577-83. PubMed ID: 3655911
    [Abstract] [Full Text] [Related]

  • 20. Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
    Fleurence J, Fougeray S, Bahri M, Cochonneau D, Clémenceau B, Paris F, Heczey A, Birklé S.
    J Immunol Res; 2017 Oct 15; 2017():5604891. PubMed ID: 28154831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.